logo

Abbvie (ABBV)



Trade ABBV now with
  Date
  Headline
11/19/2021 8:03:31 AM Allergan Aesthetics To Present Data From Its Aesthetic Portfolio
11/18/2021 7:05:38 AM AbbVie Announces Reimbursement For VENCLEXTA With Obinutuzumab For Patients With Previously Untreated CLL In Quebec
11/17/2021 2:29:51 AM AbbVie: European Commission Approves SKYRIZI For Adults With Active Psoriatic Arthritis
11/10/2021 8:31:51 AM AbbVie, University Of Chicago Extend Research Collaboration To Support Preclinical Oncology Research Through 2025
11/9/2021 8:47:56 AM AbbVie Presents New Efficacy Data On Upadacitinib In People With Active Psoriatic Arthritis And Axial Involvement
11/8/2021 8:33:42 AM Allergan To Present New Data From Eye Care Portfolio
11/5/2021 10:12:15 AM AbbVie Says Phase 3 Trials Data On Risankizumab Shows Greater Improvements In Psoriatic Arthritis Signs
11/4/2021 9:07:41 AM AbbVie To Highlight New Advances In Blood Cancer Research And Expanding Oncology Pipeline At ASH Annual Meeting
11/1/2021 8:32:29 AM AbbVie Highlights Research From Rheumatology Portfolio At ACR Convergence 2021
10/29/2021 7:52:46 AM AbbVie : Cariprazine Meets Primary Endpoint In Phase 3 Study As Adjunctive Treatment For Major Depressive Disorder
10/29/2021 7:50:22 AM AbbVie (ABBV) Declares Quarterly Dividend of $ 1.41, Record Date 1/14/2022
10/29/2021 7:49:40 AM AbbVie (ABBV) Has Raised Its FY21 EPS Estimate To 12.63 - 12.67 From 12.52 - 12.62